In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DanioLabs Ltd.

Executive Summary

DanioLabs Ltd. was established in October 2001 to develop new drugs for neuro-ophthalmologic disorders. Frustrated at the lack of effective treatments available in these areas, the company's founder set about using zebrafish models of human disease to identify both novel drug targets and effective new drugs. Zebrafish can be manipulated to provide particularly good models of a number of human diseases, including CNS, ophthalmologic, digestive and cardiovascular system disorders.


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts